Pharma Journalist - Page 95 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004

Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region

uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1

Ascletis Announces U.S. FDA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

Sun Pharma acquires Disperzyme and Phlogam brands to strengthen its anti-inflammatory portfolio

Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers

GxP Systems Validation: Not A One-Time Occurrence

Charles River Laboratories Acquires SAMDI Tech

Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar

Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev